Etoposide Completed Phase 2 Trials for Glioblastomas / Gliosarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00613028Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
NCT00612430Ph II Bevacizumab + Etoposide for Pts w Recurrent MG